Richard Pzena
Pzena Investment Management
Pzena Investment Management Portfolio 13F
Richard Pzena Holdings Activity
- Portfolio value:
- $24.61B≈ (+$3B≈)
- Previous value:
- $21.20B≈
- # of changes:
- 168
- New positions:
- 17
- Reported for:
- 31 Mar 2021 (Q1)
- Latest filing date:
- 07 May 2021
Pzena Investment Management has disclosed a total of 168 changes to the portfolio in the (2021 Q1) SEC report(s): increased the number of shares of 70, bought 17 totally new, decreased the number of shares of 68 and completely sold out 13 position(s).
What stocks did Richard Pzena buy in 2021 Q1?
During 2021 Q1 Richard Pzena has bought 87 securities out of which top 5 purchases (by % change to portfolio) were (LEA) Lear Corp (added shares +0.92%), (AIG) American International Group Inc (added shares +1.50%), (CTSH) Cognizant Technology Solutions Corp, CL-A (added shares +18.69%), (EIX) Edison International (added shares +65.29%) and (EQH) Axa Equitable Holdings Inc (added shares +1.96%).
What did Richard Pzena invest in during 2021 Q1?
In the 2021 Q1 report(s) the following changes have been made to the top investments: (GE) GE Aerospace (reduced shares -5.41%), (LEA) Lear Corp (added shares +0.92%), (AIG) American International Group Inc (added shares +1.50%), (CTSH) Cognizant Technology Solutions Corp, CL-A (added shares +18.69%) and (WFC) Wells Fargo & Company (reduced shares -1.48%).
168 results
| History | Ticker | Name |
% or activity |
Shares change |
Shares held after* |
% change to portfolio |
Reported price* |
% difference current price* |
% of portfolio |
Held since* | Held for* |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
WARNER BROS DISCOVERY INC
|
new
|
+10,476
|
10,476
|
+0%
|
$43.43
|
|
0.00%
|
2021 Q1
|
≈ 0.25 years
|
|
|
|
Meta Platforms Inc
|
new
|
+1,949
|
1,949
|
+0%
|
$294.51
|
+86.48%($549.19)
|
0.00%
|
2021 Q1
|
≈ 0.25 years
|
|
|
|
Intel Corp
|
new
|
+6,665
|
6,665
|
+0%
|
$64.07
|
+44.68%($92.69)
|
0.00%
|
2021 Q1
|
≈ 0.25 years
|
|
|
|
The J. M. Smucker Company
|
new
|
+5,733
|
5,733
|
+0%
|
$126.46
|
-4.78%($120.42)
|
0.00%
|
2021 Q1
|
≈ 0.25 years
|
|
|
|
Ziff Davis Inc
|
new
|
+4,529
|
4,529
|
+0%
|
$119.89
|
-56.29%($52.41)
|
0.00%
|
2021 Q1
|
≈ 0.25 years
|
|
|
|
Merck & Company Inc
|
new
|
+8,546
|
8,546
|
+0%
|
$77.11
|
+69.45%($130.66)
|
0.00%
|
2021 Q1
|
≈ 0.25 years
|
|
|
|
Moderna Inc
|
new
|
+3,775
|
3,775
|
+0%
|
$130.86
|
-56.82%($56.51)
|
0.00%
|
2021 Q1
|
≈ 0.25 years
|
|
|
|
MRC Global Inc
|
new
|
+1,913,515
|
1,913,515
|
+0.07%
|
$9.03
|
|
0.07%
|
2021 Q1
|
≈ 0.25 years
|
|
|
|
Revvity Inc
|
new
|
+3,473
|
3,473
|
+0%
|
$128.42
|
-12.03%($112.96)
|
0.00%
|
2021 Q1
|
≈ 0.25 years
|
|
|
|
Regeneron Pharmaceuticals Inc
|
new
|
+1,255
|
1,255
|
+0%
|
$473.31
|
+60.29%($758.68)
|
0.00%
|
2021 Q1
|
≈ 0.25 years
|
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted.